North America Attention Deficit Hyperactivity Disorder Market Size & Outlook
North America attention deficit hyperactivity disorder market, 2018-2030 (US$M)
Related Markets
North America attention deficit hyperactivity disorder market highlights
- The North America attention deficit hyperactivity disorder market generated a revenue of USD 10,635.3 million in 2023.
- The market is expected to grow at a CAGR of 3.5% from 2024 to 2030.
- In terms of segment, stimulants was the largest revenue generating drug type in 2023.
- Non-stimulants is the most lucrative drug type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 10,635.3 million |
| Market revenue in 2030 | USD 13,544.5 million |
| Growth rate | 3.5% (CAGR from 2023 to 2030) |
| Largest segment | Stimulants |
| Fastest growing segment | Non-stimulants |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stimulants, Non-stimulants |
| Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 74.3% of the global attention deficit hyperactivity disorder market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,841.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Attention Deficit Hyperactivity Disorder Market Scope
Attention Deficit Hyperactivity Disorder Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America attention deficit hyperactivity disorder market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.84% in 2023. Horizon Databook has segmented the North America attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
The North America attention deficit hyperactivity disorder market is expected to grow at a steady pace over the forecast period, owing to the launch and rapid uptake of multiple drugs. Moreover, favorable reimbursement policies, increased awareness about current treatment therapies, and improved patient affordability are expected to drive market growth over the forecast period.
The increasing number of ADHD drug users and the delays in production of medication are responsible for the shortage of medication in the market. For instance, in October 2022, pharmacies across the U.S. witnessed a shortage of Adderall and struggled to fulfill the demand gap created in the market. As per the FDA, the reason behind this dramatic situation is production delays from manufacturers due to labor shortages.
In August 2023, the FDA communicated to the public regarding the management of ADHD. It highlighted approved treatments aimed at alleviating ADHD symptoms and enhancing functionality, particularly in children as young as 6 years old. This initiative aligns with governmental efforts to address ADHD comprehensively.
Reasons to subscribe to North America attention deficit hyperactivity disorder market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America attention deficit hyperactivity disorder market databook
-
Our clientele includes a mix of attention deficit hyperactivity disorder market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America attention deficit hyperactivity disorder market , including forecasts for subscribers. This continent databook contains high-level insights into North America attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America attention deficit hyperactivity disorder market size, by country, 2018-2030 (US$M)
North America Attention Deficit Hyperactivity Disorder Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
